Global Clostridium Vaccine (Animal Health) Sales Market Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Clostridium Vaccine (Animal Health) Sales Market Report 2024
Market Analysis and InsightsGlobal Clostridium Vaccine (Animal Health) Market
Clostridium vaccines are used to provide immunity against for a variety of ovine and bovine clostridial diseases such as tetanus, black disease, pulpy kidney (enterotoxaemia), and blackleg.
Due to the COVID-19 pandemic, the global Clostridium Vaccine (Animal Health) market size is estimated to be worth US$ 417.7 million in 2024 and is forecast to a readjusted size of US$ 521.8 million by 2034 with a CAGR of 2.8% during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Bovine accounting for % of the Clostridium Vaccine (Animal Health) global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Veterinary Clinic segment is altered to an % CAGR throughout this forecast period.
The United States Clostridium Vaccine (Animal Health) market is estimated at US$ million in 2024, while China was US$ million. The proportion of the United States is % in 2024, while Chinese percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period.
The global key manufacturers of Clostridium Vaccine (Animal Health) include Bayer, Bimeda, Boehringer Ingelheim, Ceva, Elanco, Merck Animal Health, Sanofi S.A., Virbac and Zoetis, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In United States, in terms of sales revenue, in 2024, the top three players hold a share about %, while in China, top three players hold a share nearly %.
Global Clostridium Vaccine (Animal Health) Scope and Market Size
The global Clostridium Vaccine (Animal Health) market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Clostridium Vaccine (Animal Health) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2034.
Segment by Type
Bovine
Ovine
Caprine
Swine
Poultry
Veterinary Clinic
Veterinary Hospital
Veterinary Research Institute
Retail Pharmacy
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
Bayer
Bimeda
Boehringer Ingelheim
Ceva
Elanco
Merck Animal Health
Sanofi S.A.
Virbac
Zoetis
Clostridium vaccines are used to provide immunity against for a variety of ovine and bovine clostridial diseases such as tetanus, black disease, pulpy kidney (enterotoxaemia), and blackleg.
Due to the COVID-19 pandemic, the global Clostridium Vaccine (Animal Health) market size is estimated to be worth US$ 417.7 million in 2024 and is forecast to a readjusted size of US$ 521.8 million by 2034 with a CAGR of 2.8% during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Bovine accounting for % of the Clostridium Vaccine (Animal Health) global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Veterinary Clinic segment is altered to an % CAGR throughout this forecast period.
The United States Clostridium Vaccine (Animal Health) market is estimated at US$ million in 2024, while China was US$ million. The proportion of the United States is % in 2024, while Chinese percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period.
The global key manufacturers of Clostridium Vaccine (Animal Health) include Bayer, Bimeda, Boehringer Ingelheim, Ceva, Elanco, Merck Animal Health, Sanofi S.A., Virbac and Zoetis, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In United States, in terms of sales revenue, in 2024, the top three players hold a share about %, while in China, top three players hold a share nearly %.
Global Clostridium Vaccine (Animal Health) Scope and Market Size
The global Clostridium Vaccine (Animal Health) market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Clostridium Vaccine (Animal Health) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2034.
Segment by Type
Bovine
Ovine
Caprine
Swine
Poultry
Segment by Application
Veterinary Clinic
Veterinary Hospital
Veterinary Research Institute
Retail Pharmacy
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Bayer
Bimeda
Boehringer Ingelheim
Ceva
Elanco
Merck Animal Health
Sanofi S.A.
Virbac
Zoetis
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices